The incredible world of stem cells has been a topic of great interest and research for decades, opening the doors to groundbreaking therapeutic possibilities. With their unique ability to differentiate into any cell type, stem cells can potentially revolutionize how we approach medical treatment. Among the many conditions that could benefit from stem cell therapy, Autism Spectrum Disorder (ASD) has recently garnered significant attention. ASD, a developmental disorder that affects communication and social interaction, has no known cure, leaving many families searching for effective treatment options. This blog post will delve into the fascinating world of stem cell therapy, specifically focusing on its potential in treating autism. We will explore Mesenchymal Stem Cells (MSCs), a type of stem cell with exceptional therapeutic properties, and Wharton's Jelly MSCs, which are derived from the gelatinous substance within the umbilical cord. These unique cells have been found to possess remarkable regenerative and immunomodulatory capabilities, making them a promising candidate for ASD treatment. We will also discuss the role of exosomes - small vesicles that facilitate communication between cells - in stem cell therapy and their potential to promote neuroregeneration and reduce inflammation. Furthermore, we will shed light on the connection between heavy metals and gut health and how addressing these factors could play a pivotal role in enhancing the efficacy of stem cell therapy for autism. Join us as we embark on this exciting journey, unraveling the potential of stem cell therapy and its possible applications in the world of autism. As we venture into this realm of cutting-edge science, we hope to provide you with valuable insights and a newfound understanding of stem cell therapy's promise for individuals with ASD and their families.
Stem cells therapy
Stem cells are a type of cells that have the ability to divide and differentiate into various specialized cell types. They are characterized by their ability to self-renew, meaning they can replicate themselves through cell division to produce more stem cells. Stem cells are found in various tissues throughout the body and play important roles in tissue repair, maintenance, and regeneration. There are two main types of stem cells: embryonic stem cells and adult stem cells. Embryonic stem cells are derived from the inner cell mass of a blastocyst, a structure that forms during early development. These cells are pluripotent, meaning they have the ability to differentiate into any cell type in the body. Adult stem cells, on the other hand, are found in various tissues of the body and are responsible for maintaining and repairing the tissue in which they are found. They are generally more limited in their ability to differentiate compared to embryonic stem cells and are typically specific to a particular tissue type. Stem cells have the potential to be used for a wide range of therapeutic applications, including the treatment of various diseases and injuries. They are being studied for their potential to regenerate damaged tissues, such as in the treatment of heart disease, nerve damage, and diabetes. Stem cell research is a rapidly developing field with great potential for improving human health. There is currently no cure for autism, and treatment typically involves a combination of therapies, including behavioral and educational interventions, to address the various symptoms and challenges associated with the disorder. One potential role of stem cells in the treatment of autism is their ability to differentiate into various types of brain cells, including neurons and glia, which may be able to replace damaged or lost cells and potentially improve brain function. There are several theories about how stem cells may be able to help treat autism. One theory is that stem cells may be able to differentiate into various types of brain cells, including neurons and glia, which may be able to replace damaged or lost cells and potentially improve brain function in individuals with autism. In addition, stem cells may have the ability to secrete various signaling molecules, such as growth factors and cytokines, that can influence the development and function of the brain. Another theory is that stem cells may be able to improve brain function by reducing inflammation and promoting neuroplasticity, which is the ability of the brain to reorganize itself by forming new connections between neurons. Some studies have suggested that individuals with autism may have increased inflammation in the brain, which may contribute to the development and severity of the disorder. By reducing inflammation and promoting neuroplasticity, stem cells may be able to improve brain function and potentially reduce some of the symptoms of autism. A number of clinical trials have been conducted to investigate the use of stem cells as a treatment for autism, including studies using stem cells derived from umbilical cord blood and bone marrow, as well as studies using induced pluripotent stem cells (iPSCs) generated from the patient’s own skin or blood cells. One study published in the Journal of Translational Medicine in 2018 reported on the use of umbilical cord blood stem cells in a small group of children with autism. The study found that the treatment was generally well-tolerated and that there was some evidence of improvement in social interactions and communication skills in some of the children. However, the study was small and did not have a control group, making it difficult to draw firm conclusions about the effectiveness of the treatment. Another study published in the journal Stem Cells Translational Medicine in 2015 reported using iPSCs in a small group of children with autism. The study found that the treatment was well-tolerated and that there was some evidence of improvement in social interactions, communication skills, and cognitive function in some of the children. Again, the study was small and did not have a control group, so it is difficult to draw firm conclusions about the effectiveness of the treatment. It is important to note that these theories are based on preliminary research and are still being studied. More research is needed to understand the mechanisms by which stem cells may be able to help treat autism and to determine the safety and effectiveness of stem cell treatments for this disorder.
Mesenchymal stem cells
Mesenchymal stem cells (MSCs) are a type of adult stem cell that can be obtained from a patient’s bone marrow. MSCs are characterized by their ability to differentiate into various types of cells, including bone cells, cartilage cells, and fat cells. They also have the ability to secrete various signaling molecules, such as growth factors and cytokines, that can influence the development and function of tissues. Mesenchymal stem cells can be obtained from a patient’s bone marrow through a procedure called bone marrow aspiration. This involves using a needle to remove a small amount of bone marrow from the patient’s hip bone or sternum. The bone marrow is then processed in a laboratory to isolate the MSCs. Mesenchymal stem cells have been studied for their potential use in a wide range of therapeutic applications, including treating various diseases and injuries. They are being investigated for their potential to regenerate damaged tissues, such as in the treatment of heart disease, nerve damage, and diabetes. Mesenchymal stem cells obtained from a patient’s own bone marrow, referred to as autologous MSCs, may be less likely to be rejected by the patient’s immune system compared to MSCs from a donor.
Wharton’s Jelly Mesenchymal Stem Cells
Allogenic stem cells are stem cells that are obtained from a donor rather than from the patient themselves. Allogenic stem cells may be obtained from various sources, including bone marrow, cord blood, and placental tissue. Wharton’s jelly is a type of connective tissue found in the umbilical cord. It is rich in stem cells, including mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs). Allogenic stem cells obtained from Wharton’s jelly have been studied for their potential use in a wide range of therapeutic applications. They are being investigated for their potential to regenerate damaged tissues and modulate the immune response. The incorporation of stem cells as a transplant therapy treatment for autism conditions has led to further studies of regenerative engineering and tissue engineering. Umbilical cord Wharton’s Jelly (W) is critical in providing stem cells. The WJ has been found to possess the unique cell population that displays the stemness phenotype known as the mesenchymal stromal cells (MSCs). MSCs from a young WJ are more robust than adult MSCs’ immune properties and stemness (Nazempour et al., 2021). Also, MSCs from the W3 exhibit more immunosuppressive, proliferative, and therapeutically active systems than those obtained from bone marrow and adult tissue sources. An elastic Umbilical Cord (UC) connects the fetus and placenta during pregnancy, preventing compression, torsion, and bending of the umbilical arteries while promoting healthy blood flow. Anatomically, the UC is made up of one umbilical vein and two umbilical arteries, which are both encased in a particular mucous proteoglycan-rich matrix called W and covered by amniotic epithelium. More than ten years ago, WJ, which comprises a multipotent fibroblast-like MSC population, was initially discovered (Fong et al., 2012). In the past, WJ-MSCs were referred to as ‘umbilical cord matrix stem cells (UCMSCs)’ to distinguish them from MSCs separated from UC blood and endothelial cells derived from the umbilical vein (HUVEC) (UCB-MSCs). There are two different explanations for how stem cells got into the WJ. First, throughout the early stages of human development, fetal MSCs migrated in two waves. Some other MSCs became caught during these waves of migration and lived in the gelatinous WJ of the UC. Second, the cells in the WJ are early MCs that were already present in the UC matrix and came from mesenchyme (Crivelli et al., 2017). These cells may secrete a range of glycoproteins, glycosaminoglycans, mucopolysaccharides, and extracellular matrix proteins to create a gelatinous ground substance that prevents UC vasculature from strangulating during gestation. The Wharton’s Jelly - mesenchymal stromal cells (WJ-MSCs can be separated into two parts: the sub-amnion and the intervascular. Others, however, can group WJ-MSCs isolated from three different regions: the inter-vascular zone, perivascular zone, and the sub-amnion. The regions, like cells and numbers, exhibit significant differences and have different properties. The scenario hypothesizes that the pre-existing structures and stem cells are different; umbilical cord perivascular cells (HUCPVCs) and those collected from the sub-amnion (Bongo & Fong, 2013). With the tremendous growth of regenerative medicine, especially in orthopedic surgery, MSCs promise to halt or slow the ASD condition and improve the aspect of human functionality (Bongso & Fong, 2013). The MSCs collected from the autologous bone marrow concentrate (BMC) combined with the allogenic umbilical cord-derived WI results in greater awareness among patients (Alatyyat et al., 2020). Unlike the autogenic tissues, Wharton’s Jelly is available and easily accessible. W also exhibits rich extracellular matrix (ECM) properties like hyaluronic acid, sulfated proteoglycans, collagen, and chondroitin sulfate. From the above discussion, regenerative medicine through stem cell transplant for Autism can be used to treat incurable conditions (Siniscalco et al., 2018). Therapeutic effects of these conditions have proven to play a critical role in the maintenance and containment of the adverse effects of the condition on an individual. From the pathological point of view, ASD is caused by cerebral hypoperfusion degradation and immune dysfunction. When the neuronal tissue is damaged due to cerebral hypoperfusion degradation, it leads to neurotransmitter accumulation and abnormal metabolites leading to a decline in blood flow. Consequently, the intelligence Quotient also declined, which correlated with ASD. Stem cell therapy rectifies the molecular structure, and function of the damaged neuronal tissues, thereby causing the effects of therapy. The ability of the stem cells to transdifferentiate, self-renew and proliferate is a crucial stride toward treating ASD. Stem cells can inhibit the T lymphocyte pro-inflammatory cytokine production through the upregulation of the anti-inflammatory IL-10 (Fong et al., 2012). A case study of two patients by Fong et al. (2012) working on rehabilitation after being diagnosed with ASD, scored 43.25 points on the Autism Spectrum Quotient test before treatment with UC-MSCs. However, after carrying out the tests after the administration of UC-MSCs, their average score on the same Autism Spectrum Quotient test dropped to 31.25 points, 12 points from the previous test. The results indicated that the UC-MSCs therapeutic effect, which included rocking, body movements, flapping hands, restlessness, and jumping, had significantly decreased. Verbal communication and relationships with others improved (Musialek et al., 2015). Equally, they improved their speech as they could construct a sentence comprising 4-5 words compared to the 1-2 words at the beginning. In addition, patients after the UC-MSCs developed a great interest in music. They could sing along after the UC-MSC therapy, thus a good signal of the language ability improving significantly (Yang et al., 2016). The improvements in social relationships and language ability are expected to grow more over time. The development of the cognitive level did not change significantly, and it would take much longer for the neuronal cells to generate and form a network of neuronal cells (Fong et al., 2012). The ASD treatment uses the uncultured UC-MSCs derived from the umbilical cord and synergistic effect when combined with stem cell therapy and ASD special education.
Exosomes
Exosomes are small vesicles, or membrane-bound sacs produced and released by cells. They are formed from the endosomal compartment of cells and are involved in various cellular processes, including communication between cells, immune regulation, and waste removal. Exosomes are composed of a variety of biomolecules, including proteins, lipids, and nucleic acids, and are thought to play a role in the transfer of these biomolecules between cells. Exosomes have been the subject of increasing research interest in recent years due to their potential use as therapeutic agents. They have been studied for their potential to deliver various biomolecules, including proteins, nucleic acids, and drugs, to specific cells or tissues in the body. Exosomes have also been studied for their potential to modulate the immune response and to promote tissue repair and regeneration. Allogenic stem cells, autologous stem cells, and exosomes are being studied for their potential use as treatments for autism, a developmental disorder characterized by deficits in social interaction, communication, and repetitive behaviors. There is ongoing research into the potential benefits of these treatments for individuals with autism. However, it is important to note that this research is still in the early stages and the evidence to support their use as treatments for autism is limited. One potential reason for the use of allogenic stem cells from Wharton’s jelly in the treatment of autism is their potential to regenerate damaged or lost cells and improve tissue function. Allogenic stem cells, including those obtained from Wharton’s jelly, have been shown to have the ability to differentiate into various types of cells and to secrete various signaling molecules, such as growth factors and cytokines, that may influence the development and function of tissues. This may make them potentially useful for improving brain function and reducing some of the symptoms of autism. The use of autologous stem cells from bone marrow in treating autism is based on similar principles. Autologous stem cells, including mesenchymal stem cells (MSCs), have been shown to have the ability to differentiate into various types of cells and to secrete signaling molecules that may influence the development and function of tissues. They may be able to promote the repair and regeneration of damaged or lost cells and improve brain function in individuals with autism. Exosomes are also being studied for their potential use in treating autism due to their ability to deliver various biomolecules, including proteins, nucleic acids, and drugs, to specific cells or tissues in the body. Exosomes may be able to modulate the immune response and promote tissue repair and regeneration, which may be beneficial for improving brain function and reducing some of the symptoms of autism.
Heavy metal and gut health
There is some evidence to suggest that individuals with autism may have impaired detoxification of heavy metals, including mercury and lead. Heavy metal toxicity has been proposed as a potential contributing factor to the development of autism, although the evidence to support this theory is limited, and the relationship between heavy metal toxicity and autism is not fully understood. One possible explanation for impaired detoxification of heavy metals in individuals with autism is that they may have abnormalities in certain enzymes and proteins involved in the detoxification process. For example, some studies have found that individuals with autism have lower levels of certain enzymes, such as glutathione S-transferases and metallothioneins, which are involved in the detoxification of heavy metals. Another possible explanation is that individuals with autism may have impaired gut function, which could lead to the accumulation of heavy metals in the body. The gut plays an important role in the absorption and excretion of various substances, including heavy metals, and impaired gut function may contribute to the accumulation of these substances in the body. Research suggests that stem cells may be able to improve gut health and potentially reduce some of the symptoms of autism. However, it is important to note that this research is still in its early stages, and the evidence to support the use of stem cells as a treatment for autism is limited. One potential mechanism by which stem cells may improve gut health in individuals with autism is by promoting the repair and regeneration of damaged or inflamed gut tissue. Some studies have suggested that individuals with autism may have an increased risk of gastrointestinal problems, including inflammation and gut microbiota imbalances, which may contribute to the development and severity of the disorder. Stem cells may be able to promote the repair and regeneration of damaged gut tissue and potentially improve gut function. Another potential mechanism is through the secretion of various signaling molecules, such as growth factors and cytokines, which may influence the development and function of the gut. These signaling molecules may modulate the immune response and promote the repair and regeneration of damaged gut tissue. Evidence suggests that stem cells may be able to improve gut health and potentially reduce some of the symptoms of autism. However, one should note that this research is still in its early stages. One potential mechanism by which stem cells may improve gut health in individuals with autism is by promoting the repair and regeneration of damaged or inflamed gut tissue. Some studies have suggested that individuals with autism may have an increased risk of gastrointestinal problems, including inflammation and gut microbiota imbalances, which may contribute to the development and severity of the disorder. Stem cells may be able to promote the repair and regeneration of damaged gut tissue and potentially improve gut function. Another potential mechanism is the secretion of various signaling molecules, such as growth factors and cytokines, which may influence the development and function of the gut. These signaling molecules may modulate the immune response and promote the repair and regeneration of damaged gut tissue.